From April 1, 2024 to June 30, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 1,985,118 shares, representing 0.47% for CNY 38.99 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.28 CNY | -0.32% |
|
+1.24% | -24.80% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.80% | 717M | |
+63.05% | 856B | |
+38.93% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.62% | 244B | |
+4.91% | 234B | |
+16.19% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- 301263 Stock
- News Guangdong Taienkang Pharmaceutical Co., Ltd.
- Tranche Update on Guangdong Taienkang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.